Literature DB >> 29921962

Differences in the prevalence of sarcopenia in peritoneal dialysis patients using hand grip strength and appendicular lean mass: depends upon guideline definitions.

Asmat Abro1, Lara-Anne Delicata1, Surachet Vongsanim2, Andrew Davenport3.   

Abstract

BACKGROUND: Peritoneal dialysis (PD) patients with sarcopenia have increased risk of mortality. There is consensus that sarcopenia should combine assessments of muscle function and mass. We wished to determine the effect of using different operational definitions in PD patients.
METHODS: Hand grip strength (HGS) and segmental bioimpedance derived appendicular lean mass (ALM) were measured and the prevalence of sarcopenia determined using the Foundation for the National Institutes of Health Sarcopenia Project (FNIH), European Working Group on Sarcopenia Older Persons (EWGSOP), and Asian Working Group on Sarcopenia (AWGS) definitions.
RESULTS: We studied 155 PD patients, 95 men (61.3%), mean age 63.0 ± 14.9 years, 37.4% diabetic, treated by PD 9 (3-20) months with a HGS of 22.5 (15.5-30.2) kg, weight 73.6 ± 16.6 kg, % body fat 31.4 ± 4.2, and ALM index 7.52 ± 1.40 kg/m2. More patients were defined with muscle weakness using the EWGSOP compared to the FNIH criteria (X2 = 6.8, p = 0.009), whereas fewer patients met the EWGSOP criteria for muscle wasting compared to FNIH body mass index adjustment (X2 = 7.7, p = 0.006). However, when combining both criteria, there was no difference in the prevalence of sarcopenia between the different recommended definitions (11-15.5%).
CONCLUSION: We report a much lower prevalence of sarcopenia compared to studies in haemodialysis patients. Although there may be an element of patient selection bias, PD patients are not subject to changes in hydration and electrolytes with haemodialysis, which can affect HGS and muscle mass measurements. Using HGS and segmental bioimpedance we found similar prevalence of sarcopenia using EWGSOP, FNIH, AWGS definitions.

Entities:  

Mesh:

Year:  2018        PMID: 29921962     DOI: 10.1038/s41430-018-0238-3

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  12 in total

1.  The obesity paradox: A further consideration in dialysis patients.

Authors:  Piyawan Kittiskulnam; Kirsten L Johansen
Journal:  Semin Dial       Date:  2019-07-23       Impact factor: 3.455

Review 2.  Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients.

Authors:  Yuhei Otobe; Connie M Rhee; Matthew Nguyen; Kamyar Kalantar-Zadeh; Joel D Kopple
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-01-01       Impact factor: 2.894

3.  The cut-off values of handgrip strength and lean mass index for sarcopenia among patients on peritoneal dialysis.

Authors:  Xiao Xu; Zhikai Yang; Tiantian Ma; Ziqian Li; Yuan Chen; Yingdong Zheng; Jie Dong
Journal:  Nutr Metab (Lond)       Date:  2020-10-08       Impact factor: 4.169

Review 4.  Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis.

Authors:  Xiaoyu Shu; Taiping Lin; Hui Wang; Yanli Zhao; Tingting Jiang; Xuchao Peng; Jirong Yue
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-05       Impact factor: 12.910

5.  Application of the Clinical Frailty Score and body composition and upper arm strength in haemodialysis patients.

Authors:  Andrew Davenport
Journal:  Clin Kidney J       Date:  2021-11-23

6.  A Comparison of SARC-F, Calf Circumference, and Their Combination for Sarcopenia Screening among Patients Undergoing Peritoneal Dialysis.

Authors:  Yu-Li Lin; Chih-Hsien Wang; Jen-Pi Tsai; Chih-Tsung Chen; Yi-Hsin Chen; Szu-Chun Hung; Bang-Gee Hsu
Journal:  Nutrients       Date:  2022-02-22       Impact factor: 5.717

Review 7.  Assessment of uremic sarcopenia in dialysis patients: An update.

Authors:  Yu-Li Lin; Bang-Gee Hsu
Journal:  Tzu Chi Med J       Date:  2021-07-16

8.  Sarcopenia in hemodialysis patients from Buenos Aires, Argentina.

Authors:  Ruben Abdala; Elisa Elena Del Valle; Armando Luis Negri; Pablo Bridoux; Luciana Gonzalez Paganti; Marina Bravo; Luis Sintado; Paula Di Rienzo; Omar R Schiavelli; Maria Belén Zanchetta; Adrián Guinsburg
Journal:  Osteoporos Sarcopenia       Date:  2021-05-08

9.  High Salt Diet Impacts the Risk of Sarcopenia Associated with Reduction of Skeletal Muscle Performance in the Japanese Population.

Authors:  Yasuko Yoshida; Keisei Kosaki; Takehito Sugasawa; Masahiro Matsui; Masaki Yoshioka; Kai Aoki; Tomoaki Kuji; Risuke Mizuno; Makoto Kuro-O; Kunihiro Yamagata; Seiji Maeda; Kazuhiro Takekoshi
Journal:  Nutrients       Date:  2020-11-12       Impact factor: 5.717

Review 10.  Sarcopenia in Chronic Kidney Disease: A Scoping Review of Prevalence, Risk Factors, Association with Outcomes, and Treatment.

Authors:  Varvara Chatzipetrou; Marie-Josée Bégin; Mélany Hars; Andrea Trombetti
Journal:  Calcif Tissue Int       Date:  2021-08-12       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.